|
Contraceptive
Failure Rate Chart
Contraceptive Method |
Failure Rate in
Preventing Pregnancies
(pregnancies per 100 users per year with
typical use) |
Protection Against STDs |
Depo Provera Injection |
3% with typical use1 |
None |
Implanon Injection |
.05% with typical use 1 |
|
Patch (Ortho Evra) |
8%2 |
None |
Vaginal Ring (Nuva Ring) |
8%2 |
None |
Tubal Ligation |
0.5%2 |
None |
Male Sterilization |
0.15%2 |
|
Mini-pills
(progestin-only pills) |
8% with typical use1 |
None |
IUD (dependent upon type
of IUD) |
1.8%2
Paraguard .8% Mirena (LNG-IUS) .2% |
None |
Birth Control Pills |
8% with typical use2 |
None |
Condom: Male |
15% with typical use1 |
85% protection against
HIV/AIDs, some protection from other
STDs3 |
Condom: Female |
21% with typical use1 |
Some protection |
Cervical Cap
(Women who have delivered vaginally) |
32% with typical use in
women who have delivered vaginally1 |
None |
Cervical Cap
(Women who have not delivered vaginally) |
16% with typical use in
women who have not delivered
vaginally1 |
|
Reality Sponge (women
with no children |
16%2 |
None |
Reality Sponge (women
with children) |
32%2 |
None |
Diaphragm |
16% with typical use1 |
None |
Spermicide only |
29%2 |
None |
|
|
|
1Consumer Reports, Condoms
and Contraception, February 2005.
2Trussel J. Contraceptive
Efficacy. In Hatcher RA, Trussell J,
Stewart F, Nelson A, Cates W, Guest F,
Kowal D. Contraceptive Technology:
19th Revised Edition. New
York NY: Ardent Media, 2007.
3Hitchcock P. Scientific
Evidence on Condom Effectiveness for
Sexually Transmitted Disease (STD)
Prevention: Workshop Summary. Hernfon
(VA): DIANE Publishing, 2001. (From a
workshop help by the US National
Institute of Allergy and Infectious
Diseases, NIH, June 12-13, 2001.)
|
|